
The Drug Enforcement Administration (DEA) recently seized the sixth-largest amount of counterfeit fentanyl pills in U.S. history.
The DEA's Rocky Mountain Field Division announced on Nov. 17 the seizure of 1.7 million counterfeit fentanyl pills and 12 kilograms of fentanyl powder (capable of 6 million pills) from a storage unit in Highland Ranch, Colorado, a suburb of Denver. The seizure is the largest one-time seizure of counterfeit pills in Colorado history, according to the DEA.
Colorado's Douglas County Sheriff's Office was notified of the storage unit's contents when it was purchased by a winning bidder, according to the DEA.
"This played out like an episode of a TV show," David Olesky, DEA Rocky Mountain Field Division special agent in charge, said in a news release.
The registered owner of the storage unit is already in federal custody as the seizure is connected with an ongoing DEA and Colorado Bureau of Investigation case. The DEA did not provide more information about the case when contacted by USA TODAY on Nov. 18.
What are counterfeit fentanyl pills?
Counterfeit pills are fake medications that contain different ingredients than the intended medication, according to the DEA. The pills look nearly identical to real prescriptions like Xanax and Adderall.
In the case of counterfeit fentanyl pills, the medication capsule contains fentanyl powder.
Where do counterfeit pills come from?
Per the DEA, most counterfeit pill production occurs in China, Mexico and India. But in recent years, more have been made in the U.S. The pills are popularly sold on social media and internet marketplace.
Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at [email protected].
This article originally appeared on USA TODAY: 1.7 million counterfeit fentanyl pills seized in Colorado storage unit
LATEST POSTS
- 1
'Harry Potter' fans rejoice: HBO releases 1st trailer for new TV series, set to premiere this Christmas - 2
How did life begin on Earth? New experiments support 'RNA world' hypothesis - 3
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer - 4
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial - 5
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
HGV driver recruited others to smuggle migrants
You finally got a doctor's appointment. Here's how to get the most out of it
The Way to Business: Startup Illustrations Learned
Ever Wonder What An EV Motorcycle Water Crossing Would Be Like? Here You Go
Grass Care Administrations for a Wonderful, Sound Yard
US healthcare spending soars to over $5 trillion in 2024
Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
Top 20 Compelling Business Books for Progress
3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast













